Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello, ladies and gentlemen, and welcome to the Autolus ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

He described the autologous CAR T-cell process as, “the reprogramming of the patient's own T cells to directly attack the ...

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and ...

Ensuring Product Quality with Key Process Enhancements PyroGenesis Canada is always actively exploring ways to refine HSPI's ...

To date, the study has enrolled 8 patients with relapsed/refractory EWS (>1 remission) treated with the combination of elraglusib ... including but not limited to that clinical and preclinical drug ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

RHI Magnesita, the leading global supplier of heat management solutions, have released their Q324 financial results ...

A team of researchers from Xi'an Jiaotong University, Tianmushan Laboratory, and the National University of Singapore has ...

Vitaly Nesis also informed President Tokayev about the Company's acquisition of a 55% interest in Syrymbet, an undeveloped polymetallic deposit located in North-Kazakhstan region.

A team of researchers from Xi’an Jiaotong University, Tianmushan Laboratory, and the National University of Singapore has pioneered a new method for crafting an ultra-strong, ductile alloy using 3D ...